Levosimendan reduces mortality in cardiac surgery: A systematic review and meta-analysis;Levosimendán disminuye la mortalidad en cirugía cardíaca: Revisión sistemática y metaanálisis

Revista Espanola de Anestesiologia y Reanimacion

Volumn 59, Issue 1, 2012, Pages 6-11

  Hernandez A ^a   Miranda, A ^b   Parada, A ^b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

Cardiac surgery; Extracorporeal circulation; Levosimendan; Meta analysis

Indexed keywords

CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN; VASODILATOR AGENT;

HEART SURGERY; HUMAN; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATIONS;

CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; HUMANS; HYDRAZONES; POSTOPERATIVE COMPLICATIONS; PYRIDAZINES; VASODILATOR AGENTS;

EID: 84864300902     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2012.02.001     Document Type: Article

References (16)

1. Thackray S., Eastaugh J., Freemantle N., Cleland J.G. The effectiveness. and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: A meta-regression analysis. Eur J Heart Fail 2002, 4:515-529.
2. Lilleberg J., Nieminem S., Akkila J., Kuitunen A., Lehtonen L., Verkkala K., et al. Effects of a new calcium sensitizer, levosimendan,.on hemodynamics, coronary blood flow an myocardial substrate utilization early after coronar artery bypass grafting. Eur J Heart Fail 1998, 19:660-668.
3. Slawsky M.T., Colucci W.S., Gottlieb S.S., Greenberg B.H., Haeusslein E., Hare J., et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000, 102:2222-2227.
4. Yilmaz M.B., Yalta K., Yontar C., Karadas F., Erdem A., Turgut O.O., et al. Levosimendan improves renal function in patients with acute. decompensated heart failure: comparison with dobutamine. Cardiovasc Drugs Ther 2007, 21:431-435.
5. Kivikko M., Lehtonen L., Colucci W.S. Sustained hemodynamic effects of intrevenous levosimendan. Circulation 2003, 107:81-86.
6. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., et al. Efficacy and safety of intravenous levosimendan compared. with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002, 360:196-202.
7. Moiseyev V.S., Poder P., Andrejevs N., Ruda M.Y., Golikov A.P., Lazebnik L.B., et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo. controlled, double-blind study (RUSSLAN). Eur Heart J 2002, 23:1422-1432.
8. Coletta A.P., Cleland J.G.F., Freemantle N., Clark A.L. Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. Eur J Heart Fail 2004, 6:673-676.
9. Nieminen M.S., Bohm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. Rev Esp Cardiol 2005, 58:389-429.
10. Egger M., Smith G.D., Schneider M., Zinder Ch. Bias in meta-analysis. detected by a simple, graphical test. BMJ 1997, 315:629-634.
11. Lehmann A., Kiessling A.H., Isgro F., Zeitler C., Thaler E., Boldt J. Levosimendan in patients with acute myocardial ischaemia undergoing. emergency surgical revascularization. Eur J Anaesth 2008, 25:224-229.
12. Nieminen M.S., Böhm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005, 26:384-416.
13. Álvarez J., Bouzada M., Fernández A.L., Caruezo V., Taboada M., Rodríguez J., et al. Comparación de los efectos hemodinámicos del levosimendán con la dobutamina en pacientes con bajo gasto después de cirugía cardiaca. Rev Esp Cardiol 2006, 59:338-345.
14. Levin R.L., Degrange M.A., Porcile R., Salvagio F., Blanco N., Botbol A.L., et al. Superioridad del sensibilizante al calcio Levosimendán. comparado con dobutamina en el síndrome de bajo gasto cardiaco postoperatorio. Rev Esp Cardiol 2008, 61:471-479.
15. Zangrillo A., Biondi-Zoccai G., Mizzi A., Bruno G., Bignami E., Gerli C., et al. Levosimendán reduces cardiac troponin release after cardiac. surgery: A meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009, 23:474-478.
16. Landoni G., Mizzi A., Biondi-Zoccai G., Bruno G., Bignami E., Corno L., et al. Reducing mortality in cardiac surgery with Levosimendán:. a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth 2010, 24:51-57.